General Biologicals Corp. Chairman & CEO Danner Lab Inc Chairman & CEO Pacgen Life Science Chairman & CEO CurieMed Corporation Chairman & CEO GB GENES CORP. Board director Taiwan Genomic Industry Alliance Inc. Board Director Ace Medical Technology Co., Ltd Board Director
Mr. Frank Lin
President
Director of General Biologicals Corp. GB GENES CORP. Chairman Director of GB GENES CORP. Representative of Juristic Person of GB GENES CORP. Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Ms. Cherie Lin
VP Healthcare
B.A.in New York University, Master of Business. 10+ Extensive experiences and roles in sales marketing. Supervising clinical laboratory and a clinic.
Mr. Leo Liu
VP
1998-Head of Laboratory Department, Chenxin Hospital 2002-Head of Department of Nuclear Medicine Immunology Laboratory, Hsinchu Hospital 2005-Director of Quality Control Department of CurieMed Corp 2010-Director of CurieMed Corp Medical Laboratory 2013-Director of Quality Control Department of General Biologicals Corp. 2014-General Biologicals Corp. Senior Project Manager 2019-General Biologicals Corp. Director
Mr. Wally Fan
Director, International Sales
The Open University of Hong Kong Postgraduate Certificate in Business Administration 1996-Thermo Fisher Scientific commercial leader Northeast Asia 2012-DYNEX TECHNOLOGIES, Inc. Asia Pacific Sales Director
Board Members
T.C. Lin
General Biologicals Corp. Chairman & CEO Danner Lab Inc Chairman & CEO Pacgen Life Science Chairman & CEO CurieMed Corporation Chairman & CEO GB GENES CORP. Board director Taiwan Genomic Industry Alliance Inc. Board Director Ace Medical Technology Co., Ltd Board Director
Pi-Hua Chen
CHLITINA Holding Limited. Chairman
Representative of Juristic Person of General Biologicals Corp.
Frank Lin
General Biologicals Corp. General Manager Director of General Biologicals Corp. GB GENES CORP. Chairman Director of GB GENES CORP. Representative of Juristic Person of GB GENES CORP. Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Jia-Zhen Lin
Coming Soon
Jian-Zhi Yeh
Coming Soon
Board Members
Cheng-Hua Li (Independent Director and Audit Committee Member)
Coming Soon
Jen-Leigh Wu (Independent Director and Audit Committee Member)
Academia Sinica Visiting Chair Professor NCKU Adjunct Professor Moderator of the Ministry of Science and Technolohy NTOU National Taiwan Ocean University Chair Professor Independent Director, PRIT Biotech Co. Ltd. Independent Director, General Biologicals Corp.
Cheryl Lin (Independent Director and Audit Committee Member)
President, Glonova Co. Consultant, T-TOP Clinical Research Co. Director, Yolk Partners Co. Independent Director, General Biologicals Corp.
Rui-Hsun Chen (Independent Director and Audit Committee Member)
Coming Soon
Reveal. Better Life.
Brand Story
General Biologicals Corporation (GBC) — Advancing Diagnostics, Empowering Better Health
Founded in 1984, General Biologicals Corporation (GBC) is a pioneer in Taiwan’s in-vitro diagnostics (IVD) industry, originating from the National Hepatitis Prevention Program initiated by the Executive Yuan. For over 40 years, GBC has been committed to developing accurate, innovative, and accessible diagnostic solutions that improve global healthcare outcomes.
As a GMP-certified and ISO 13485-compliant manufacturer, GBC specializes in the research, development, production, and worldwide distribution of IVD products and technologies. Our solutions are trusted in 40+ countries, supporting hospitals, clinical laboratories, blood banks, and healthcare professionals with reliable diagnostic tools.
Our Core Expertise • Infectious & Respiratory Diseases • Blood-Borne Viruses • Fertility & Sexual Health • Oncology & Tumor Markers • Human Genetics • Emerging Infectious Diseases
Leveraging advanced protein and nucleic acid diagnostic platforms, GBC has built a fully integrated value chain — from R&D and manufacturing to clinical applications and laboratory services — driving innovation in precision diagnostics.
Looking ahead, GBC is expanding beyond traditional IVD into high-value, integrated healthcare solutions through its subsidiaries: • CurieMed & Danner Lab — Digital medical diagnostics and clinical laboratory services • GBP — Antimicrobial peptide (AMP) drug development and consumer healthcare applications
With global reach, cutting-edge technologies, and a mission to make world-class diagnostics affordable and accessible to all, GBC continues to transform healthcare and empower better lives.
Vision
To lead the world in integrated diagnostics and healthcare innovation, setting the benchmark for quality, accessibility, and trust.
Mission
To create and deliver state-of-the-art diagnostic and healthcare technologies that transform clinical decisions and improve lives worldwide.
Values That Drive Our Innovation
Integrity
We embrace honesty, transparency, and accountability to build lasting trust and shared growth with our employees, customers, and partners.
Insight
We anticipate healthcare trends and proactively innovate to empower our customers to achieve their goals effectively.
Integration
We connect people, knowledge, and technologies to create seamless solutions across diagnostics, pharma, and consumer health.
Innovation
Innovation is at our core. We continuously enhance our technologies and solutions to advance diagnostics and improve global healthcare.
Security
From safeguarding population health through diagnostics to ensuring our employees’ well-being, we maintain rigorous research, manufacturing, and workplace standards.
Solution
Beyond manufacturing, we deliver knowledge, expertise, and personalized solutions that address the unique needs of every customer and industry.
Adaptability
In a rapidly evolving healthcare landscape, we remain agile—adapting swiftly to changing technologies, regulations, and customer expectations.
All
Danner Lab Inc Chairman & CEO
Pacgen Life Science Chairman & CEO
CurieMed Corporation Chairman & CEO
GB GENES CORP. Board director
Taiwan Genomic Industry Alliance Inc. Board Director
Ace Medical Technology Co., Ltd Board Director